NO991734D0 - Pyrazolinones for the treatment of potency disorders - Google Patents
Pyrazolinones for the treatment of potency disordersInfo
- Publication number
- NO991734D0 NO991734D0 NO991734A NO991734A NO991734D0 NO 991734 D0 NO991734 D0 NO 991734D0 NO 991734 A NO991734 A NO 991734A NO 991734 A NO991734 A NO 991734A NO 991734 D0 NO991734 D0 NO 991734D0
- Authority
- NO
- Norway
- Prior art keywords
- pyrazolinones
- treatment
- potency disorders
- potency
- disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19642284A DE19642284A1 (en) | 1996-10-14 | 1996-10-14 | Pyrazolinones for the treatment of erectile dysfunction |
PCT/EP1997/005532 WO1998016224A1 (en) | 1996-10-14 | 1997-10-08 | Pyrazolinones to treat disturbances of potency |
Publications (2)
Publication Number | Publication Date |
---|---|
NO991734D0 true NO991734D0 (en) | 1999-04-13 |
NO991734L NO991734L (en) | 1999-04-13 |
Family
ID=7808669
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO991734A NO991734L (en) | 1996-10-14 | 1999-04-13 | Pyrazolinones for the treatment of potency disorders |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0930881A1 (en) |
JP (1) | JP2001501958A (en) |
KR (1) | KR20000049086A (en) |
CN (1) | CN1233178A (en) |
AR (1) | AR008494A1 (en) |
AU (1) | AU4945297A (en) |
BR (1) | BR9712307A (en) |
CA (1) | CA2268823A1 (en) |
DE (1) | DE19642284A1 (en) |
HU (1) | HUP0000233A3 (en) |
NO (1) | NO991734L (en) |
PL (1) | PL332821A1 (en) |
WO (1) | WO1998016224A1 (en) |
ZA (1) | ZA979151B (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6410584B1 (en) | 1998-01-14 | 2002-06-25 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells with indole derivatives |
US6200771B1 (en) | 1998-10-15 | 2001-03-13 | Cell Pathways, Inc. | Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia |
US6133271A (en) * | 1998-11-19 | 2000-10-17 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives |
US6187779B1 (en) | 1998-11-20 | 2001-02-13 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure to 2,8-disubstituted quinazoline derivatives |
US6369092B1 (en) | 1998-11-23 | 2002-04-09 | Cell Pathways, Inc. | Method for treating neoplasia by exposure to substituted benzimidazole derivatives |
US6486155B1 (en) | 1998-11-24 | 2002-11-26 | Cell Pathways Inc | Method of inhibiting neoplastic cells with isoquinoline derivatives |
US6077842A (en) * | 1998-11-24 | 2000-06-20 | Cell Pathways, Inc. | Method of inhibiting neoplastic cells with pyrazolopyridylpyridazinone derivatives |
US6034099A (en) * | 1998-11-24 | 2000-03-07 | Cell Pathways, Inc. | Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones |
US6875575B1 (en) | 1998-11-25 | 2005-04-05 | Osi Pharmaceuticals, Inc. | Diagnostic methods for neoplasia |
US6020379A (en) * | 1999-02-19 | 2000-02-01 | Cell Pathways, Inc. | Position 7 substituted indenyl-3-acetic acid derivatives and amides thereof for the treatment of neoplasia |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9301192D0 (en) * | 1993-06-09 | 1993-06-09 | Trott Francis W | Flower shaped mechanised table |
DE19518082A1 (en) * | 1995-05-17 | 1996-11-21 | Merck Patent Gmbh | 4 (-Arylaminomethylene) -2,4-dihydropyrazol-3-one |
-
1996
- 1996-10-14 DE DE19642284A patent/DE19642284A1/en not_active Withdrawn
-
1997
- 1997-10-08 HU HU0000233A patent/HUP0000233A3/en unknown
- 1997-10-08 JP JP10517987A patent/JP2001501958A/en active Pending
- 1997-10-08 EP EP97912141A patent/EP0930881A1/en not_active Withdrawn
- 1997-10-08 CN CN97198764A patent/CN1233178A/en active Pending
- 1997-10-08 WO PCT/EP1997/005532 patent/WO1998016224A1/en not_active Application Discontinuation
- 1997-10-08 PL PL97332821A patent/PL332821A1/en unknown
- 1997-10-08 BR BR9712307-2A patent/BR9712307A/en not_active Application Discontinuation
- 1997-10-08 AU AU49452/97A patent/AU4945297A/en not_active Abandoned
- 1997-10-08 CA CA002268823A patent/CA2268823A1/en not_active Abandoned
- 1997-10-08 KR KR1019990703161A patent/KR20000049086A/en not_active Application Discontinuation
- 1997-10-13 ZA ZA9709151A patent/ZA979151B/en unknown
- 1997-10-14 AR ARP970104715A patent/AR008494A1/en unknown
-
1999
- 1999-04-13 NO NO991734A patent/NO991734L/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR008494A1 (en) | 2000-01-19 |
JP2001501958A (en) | 2001-02-13 |
AU4945297A (en) | 1998-05-11 |
ZA979151B (en) | 1998-05-11 |
BR9712307A (en) | 1999-08-31 |
DE19642284A1 (en) | 1998-04-16 |
CN1233178A (en) | 1999-10-27 |
CA2268823A1 (en) | 1998-04-23 |
HUP0000233A3 (en) | 2001-06-28 |
KR20000049086A (en) | 2000-07-25 |
EP0930881A1 (en) | 1999-07-28 |
PL332821A1 (en) | 1999-10-11 |
HUP0000233A2 (en) | 2001-04-28 |
WO1998016224A1 (en) | 1998-04-23 |
NO991734L (en) | 1999-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO986052D0 (en) | Anticonvulsant derivatives for the treatment of obesity | |
NO991955D0 (en) | Process for the treatment of hydrocarbons | |
NO306977B1 (en) | Use of thienol [1,5] benzodiazepine for the treatment of gastrointestinal disorders | |
NO970153L (en) | Process for the Synthesis of Substituted Sulfoxides | |
NO965377L (en) | Indolinone compounds for the treatment of diseases | |
IL129998A0 (en) | Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases | |
NO20003042D0 (en) | Procedure for the prophylactic treatment of mastitis | |
NO991459L (en) | Use of 1-hydroxy-2-pyridones for the treatment of skin infections | |
ID27214A (en) | TRIAZOLOPIRIDINA FOR TREATMENT OF TROMBOSIS DISORDERS | |
NO991734D0 (en) | Pyrazolinones for the treatment of potency disorders | |
NO984432D0 (en) | Procedure for the treatment of migraine pain | |
NO996432L (en) | Process for the preparation of 4-substituted-1H-indole-3-glycosamides | |
NO973366D0 (en) | Procedure for the treatment of multiple sclerosis | |
NO985535L (en) | Process for the preparation of 1,3-alkanediols | |
NO983784D0 (en) | Processes for the preparation of biphenyl-isoxazole sulfonamides | |
NO982562D0 (en) | Composition for the treatment of pain | |
NO20012612D0 (en) | Isonipecotamides for the treatment of integrin-mediated disorders | |
NO991158D0 (en) | Procedure for the treatment of amyotrophic lateral sclerosis | |
NO984189D0 (en) | Procedure for the treatment of bipolar disorder | |
NO953089L (en) | Steroids for the treatment of menopausal disorders | |
NO993549L (en) | Imino-aza-anthracycline derivatives for the treatment of amyloidosis | |
NO952411D0 (en) | Means for the treatment of metabolic bone disorders | |
NO986053D0 (en) | Anticonvulsant derivatives for the treatment of psoriasis | |
NO20003077L (en) | Process for the preparation of the chlorobenzoxazole | |
NO962812D0 (en) | Procedure for the treatment of pneumonia |